Abstract
To identify clinically relevant downstream effectors of androgen signaling, the androgen-regulated kinome was defined in prostate cancer (PCa). Within this study, choline kinase α (CHKA) was identified as an androgen receptor chaperone that is both a biomarker of progression and a potential therapeutic target for PCa.
Original language | English |
---|---|
Article number | e1140262 |
Journal | Molecular and Cellular Oncology |
Volume | 3 |
Issue number | 3 |
DOIs | |
State | Published - May 3 2016 |
Externally published | Yes |
Keywords
- Androgen Receptor
- chaperones
- prostate cancer
- therapeutic target